Support Line: 0800 002 9002
General Enquiries: 01223 870008
  »  Kidney Cancer News  »  EU kidney cancer clinical guidelines updated

EU kidney cancer clinical guidelines updated

by | Mar 31, 2022 | Kidney Cancer News | 0 comments

Updated clinical guidelines published by the European Association of Urologists.

The European Association of Urology (EAU) has announced the latest update to its Clinical Guidelines on Kidney Cancer. In this latest version, the EAU has added further references, which in some cases have led to changes in their recommendations. The EAU lists eighteen modified recommendations in its summary of the changes.

The EAU guidelines have an important impact on kidney cancer diagnosis, treatment and care in the UK. However, in England and Wales, the National Institute for Health and Care Excellence (NICE) is responsible for producing clinical guidelines for the NHS, as well as recommendations on the use (or not) of individual drugs, and surgical and diagnostic techniques which are mandatory*.

The need for a NICE guideline

*Scotland has developed separate kidney cancer indicators against which diagnosis and treatment standard are measured.

The main changes in the EAU guidelines are:

  • More targeted approach to biopsy testing of kidney cysts that will reduce the number of unnecessary biopsies
  • Enhanced measures to identify hereditary kidney cancer, including  referring people who have hereditary factors to a specialist centre
  • Additional recommendations for the treatment of metastatic clear cell kidney cancer with immunotherapy.
<a href="" target="_self">Kidney Cancer UK</a>

Kidney Cancer UK

Kidney Cancer UK is the UK’s leading kidney cancer charity. We seek to reduce the harm caused by kidney cancer by increasing knowledge and awareness, providing patient information and by supporting research into the causes, prevention and treatment of the disease